Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the schedule hereto:
Schedule
Product: Bicillin L-A Tubex
Active Ingredient(s): Benzathine penicillin (anhydrous) 600,000U/mL
Dosage Form: Suspension for injection
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer(s): Wyeth-Ayerst Laboratories, West Chester, Pennsylvania, United States of America
Note: This consent is valid for 2 years from 26 April 2000.
Product: Taxotere
Active Ingredient(s): Docetaxel (trihydrate) 40mg/mL
Dosage Form: Concentrate for infusion
New ZealandSponsor: Aventis Pharma Limited
Manufacturer(s): Rhone-Poulenc Rorer Limited, Dagenham, Essex, United Kingdom
Rhone-Poulenc Rorer SA, Vitry sur Seine, France
Note: This consent is valid for 2 years from 23 May 2000.
Dated this 15th day of April 2000.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).